Article
YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance
1 Jun 2022
Abstract excerpt
Malignant melanoma, with its increasing incidence and high potential to form metastases, is one of the most aggressive types of skin malignancies responsible for a significant number of deaths worldwide. However, melanoma also demonstrates a high potential for induction of a specific adaptive anti-tumor immune response being one of the most immunogenic malignancies. Yin Yang 1 (YY1) transcription factor is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
